Related Experiment Video
Updated: Aug 7, 2026

Cytosolic Calcium Measurements in Renal Epithelial Cells by Flow Cytometry
Published on: October 28, 2014
Effect of hydrochlorothiazide on renal hypercalciuria
I Voskaki1, A al Qadreh, C Mengreli
1Institute of Child Health, Aghia Sophia Children's Hospital, Athens, Greece.
Insights
Hydrochlorothiazide (HCT) effectively treats renal hypercalciuria in children, reducing urinary calcium and preventing kidney stones. This long-term study found no adverse effects, showing significant improvements in bone mineral content.
Area of Science:
- Pediatric Nephrology
- Pharmacology
Background:
- Renal hypercalciuria (HCU) is a condition characterized by excessive calcium excretion in the urine.
- Long-term management strategies for pediatric HCU are crucial for preventing kidney stone formation and preserving bone health.
Purpose of the Study:
- To evaluate the long-term efficacy and safety of hydrochlorothiazide (HCT) in pediatric patients with renal hypercalciuria.
- To assess the impact of HCT on renal calcium excretion, serum biochemistry, and bone mineral content.
Main Methods:
- A cohort of 30 children (aged 4-13 years) with HCU received 1 mg/kg/day of HCT for an average of 2.5 years.
- Comprehensive monitoring included urinary calcium, serum electrolytes, parathyroid hormone, nephrogenic cAMP, and bone mineral content.
Main Results:
- HCT demonstrated rapid and sustained correction of HCU.
- Significant increases in bone mineral content and reductions in serum cPTH and ncAMP were observed.
- The treatment effectively prevented new stone formation or growth of existing stones, with no reported side effects.
Conclusions:
- Hydrochlorothiazide is a safe and effective long-term treatment for renal hypercalciuria in children.
- HCT improves bone mineral density and reduces the risk of kidney stone recurrence in this pediatric population.
Abstract:
The long-term effect of hydrochlorothiazide (HCT) was studied in 30 children (17 boys and 13 girls), aged 4-13 years (mean 7.6 +/- 3.4), with renal hypercalciuria (HCU) for a period of 2.5 +/- 0.95 years. The purpose of the study was to evaluate the effect of HCT mainly on renal calcium excretion, but also on serum K+, Ca, P, Mg, cPTH, nephrogenic cAMP (ncAMP) and bone mineral content (BMC). In addition to the above-mentioned parameters, oxalate, uric acid, citrate and cystine levels in 24-hour urine collections were also measured, and UCa/UCr, UP/UCr, UMg/UCr in 3-hour urine collections were assayed. The results of the study showed that 1 mg/kg/day of HCT caused a rapid and long-lasting correction of HCU, a decrease in serum cPTH and ncAMP, a significant increase in BMC and prevention of the formation of new urinary stones or of the increase in size of stones already present. No side effects were observed.
Related Concept Videos
Antihypertensive Drugs: Action of Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Urinary Tract Calculi I: Introduction
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi III: Medical Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention

